Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A phase 1b clinical trial, published this week in Nature Medicine, reveals promising early results for a novel treatment combination involving quemliclustat, a CD73 inhibitor, alongside standard chemotherapy (gemcitabine and ... Read More
Continuous Coverage
The desert air crackled with more than just heat this week. A U.S. Marine stationed in California, 26-year-old…
Colorado Governor Jared Polis has publicly thanked Kim Bimestefer for her nine years of service as Executive Director…
Wisconsin Governor Tony Evers is poised to decide the fate of a bill legalizing online sports betting within…
A youth football coach, during a game on March 30th, 2026, instigated a physical altercation with referees, reportedly…
Molecular Control via UV: A Paradigm Shift in Microfluidics and Beyond Researchers at the University of Tokyo have…
The International Monetary Fund (IMF) issued a stark warning on March 30, 2026, that continued conflict in the…
Global Affairs
Iran’s parliament approved a bill late Tuesday imposing transit fees on all vessels traversing the Strait of Hormuz,…
Markets And Money
Slovakia’s Železiarne Podbrezová, a major steel producer, reported further losses in 2025, exceeding several million euros. This follows…
Digital Culture
A 18-million-year-old ape fossil, Masripithecus moghraensis, discovered in Northern Egypt, challenges the longstanding East African origin theory of…
Science And Wellbeing
New Study Links HIV Treatment Switch to Increased Diabetes Risk A recently published study from Johns Hopkins Medicine…
Screen And Sound
JTBC’s upcoming drama, “We Are All Trying Here,” starring Travel Youn Jung and Koo Kyo Hwan, is generating…
Fixtures And Form
Liverpool is poised to make Yan Diomande their third-most expensive signing ever at a reported €100m, while a…
